Introduction
============

In dialysis patients, a number of studies have suggested that hypoalbuminemia is an independent predictor of increased cardiovascular events and mortality ([@b18-vhrm-4-0871]; [@b33-vhrm-4-0871]; [@b10-vhrm-4-0871]; [@b23-vhrm-4-0871]). There are also reports that hypoalbuminemia is closely associated with left ventricular hypertrophy (LVH) in dialysis patients ([@b17-vhrm-4-0871]; [@b16-vhrm-4-0871]). However, the underlying mechanism by which hypoalbuminemia leads to LVH and increased cardiovascular events remains unclear. In recent years, many studies have also proved that increased aortic stiffness is a risk factor for cardiovascular events and mortality ([@b3-vhrm-4-0871]; [@b2-vhrm-4-0871]; [@b24-vhrm-4-0871]; [@b20-vhrm-4-0871]). It is thus reasonable to hypothesize that there might be a close association between hypoalbuminemia and markers of aortic stiffness.

In our previous study, we found a negative correlation between serum albumin and pulse pressure (PP), the surrogate of arterial stiffness ([@b32-vhrm-4-0871]; [@b13-vhrm-4-0871]; [@b31-vhrm-4-0871]) in a group of continuous ambulatory peritoneal dialysis (CAPD) patients (unpublished data). However, PP is not the true marker of arterial stiffness. Therefore, in the present study, we employed pulse wave velocity (PWV), the direct measure of arterial stiffness ([@b26-vhrm-4-0871]), and explored the relationship between serum albumin and PWV in CAPD patients. To clarify the confounding effect of inflammation, we additionally analyzed the relationship between serum albumin and PWV in a subgroup of patients without evidence of inflammation.

Patients and methods
====================

Study population
----------------

In this cross-sectional study, we included all stable patients treated with CAPD in the Peritoneal Dialysis Center of Peking University Third Hospital in May, 2006. The exclusion criteria were: 1) dialysis duration less than 3 months; 2) presence of congestive heart failure; and 3) hypotension (defined as systolic blood pressure/diastolic blood pressure \<90/60 mmHg). Based on these criteria, 62 patients were considered suitable for this study. The study protocol was approved by the ethic committee of our hospital and informed consent was obtained from every patient.

Measurement of carotid-femoral pulse wave velocity
--------------------------------------------------

Aortic PWV was determined using an automatic device, the Complior (Colson, Garges les Gonesses, France) ([@b1-vhrm-4-0871]), which allowed online pulse wave recording and automatic calculation of PWV. Common carotid artery and femoral artery pressure wave forms were recorded noninvasively using a TY-306 Fukuda pressure sensitive transducer (Fukuda, Tokyo, Japan). Measurement was repeated over 10 different cardiac cycles, and the mean value was used for the final analysis. The distance traveled by the pulse wave was measured over the body surface as the distance between the two recording sites (D), while pulse transit time (t) was automatically determined by the Complior. Pulse wave velocity was automatically calculated as PWV = D/t. Details, as well as validation of this automatic method and its reproducibility, have been reported previously ([@b1-vhrm-4-0871]). All the PWV measurements were performed by one doctor (L-J Tang) and the intra-observer CV was about 1.74%--7.95%.

Measurement of blood pressure
-----------------------------

To ensure the accuracy of measurements, a dedicated renal nurse was in charge of all blood pressure (BP) measurements, and the mercury sphygmomanometer used was calibrated regularly. All measurements were performed in a quiet room. Brachial BP was measured twice in a sitting position after patients had rested more than ten minutes. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were averaged from values of the two measurements.

Biochemical measurements
------------------------

Serum albumin was determined by the bromcresol green method. High sensitive C-reactive protein (CRP) was measured as inflammatory index and a CRP value ≥3 mg/L was considered as the presence of inflammation. This method could not detect CRP levels \<0.01 mg/L. Other biochemical indices, such as serum calcium, phosphate, triglycerides, total cholesterol lipoprotein, low-density lipoprotein, and high-density lipoprotein were determined with standard methods.

Measurements of fluid status
----------------------------

Extracellular water(ECW) was measured by multiple-frequency bioelectrical impedance analysis (Xitron Technologies, San Diego, CA). The procedure to perform this measurement was described in detail elsewhere ([@b9-vhrm-4-0871]). Briefly, after patients taking supine position for at least 10 minutes, the standard tetrapolar electrodes were placed on the dorsum of wrist and anterior aspect of the ankle on the left side of the body. Three consecutive measurements were performed over a 2-min period, and ECW was calculated as the mean values of the three measurements.

Statistical analysis
--------------------

Continuous variables were expressed as mean ± SD while categorical variables were expressed as percentage or ratio. Pearson's and Spearman's correlations were performed to explore the relationships between serum albumin and other variables as appropriate. Multiple regression analysis was performed to determine the relationship between serum albumin and PWV to control the influence of other variables. All tests were two-sided. A value of P \< 0.05 was taken as statistically significant. All analysis was completed with SPSS software, version 11.0 (SPSS, Chicago, IL).

Results
=======

Demographic characteristics of the study population
---------------------------------------------------

The demographic characteristics of the patients included in this study were shown in [Table 1](#t1-vhrm-4-0871){ref-type="table"}. There were 27 male and 35 female patients, with an average age of 63 ± 12 years old (range 23 to 85). The mean dialysis duration in these patients was 23 ± 22 months. The mean serum albumin was 37 ± 4 g/L. The mean PWV was 11.96 ± 2.27 m/s.

Univariate correlation multiple regression analysis
---------------------------------------------------

Univariate correlation analysis between PWV and other possible affecting factors were shown in [Table 2](#t2-vhrm-4-0871){ref-type="table"}. PWV was positively correlated with age (r = 0.35, P \< 0.01), diabetic status (yes = 1, no = 0; r = 0.292, P \< 0.05), SBP (r = 0.493, P \< 0.001) and CRP (r = 0.295, P \< 0.05), but negatively correlated with serum albumin (r = --0.357, P \< 0.01; [Figure 1A](#f1-vhrm-4-0871){ref-type="fig"}). The correlations between PWV and ECW and phosphate were just borderline (r = 0.241, P = 0.077 and r = --0.244, P = 0.056, respectively). No correlation was found between PWV and sex (female = 1, male = 0), height, dialysis duration, DBP, antihypertensive medication (yes = 1, no = 0), serum calcium, and total cholesterol.

Multiple stepwise regression analysis to determine the relationship between PWV and other possible affecting factors was shown in [Table 3](#t3-vhrm-4-0871){ref-type="table"}. In this model, PWV was treated as dependent variable while a series of factors were treated as independent variables, such as age, sex (female = 1, male = 0), dialysis duration, diabetic status (yes = 1, no = 0), SBP, DBP, antihypertensive medication (yes = 1, no = 0), ECW, serum calcium, serum phosphate, total cholesterol, CRP, and serum albumin. The result of multiple stepwise regression analysis showed that SBP (0.615, P \< 0.001), age (0.414, P \< 0.01), serum albumin (--0.315, P \< 0.05) and total cholesterol (0.275, P \< 0.05) were independent determinants of PWV after adjusting other possible confounding factors. The adjusted R Square for this model was 0.627.

Univariate correlation analysis in patients without inflammation
----------------------------------------------------------------

To exclude the confounding effect of inflammation on correlation between serum albumin and PWV, univariate correlation analysis was further performed in patients without evidence of inflammation. Among the 62 patients, 30 patients with CRP values less than 3 mg/L were considered as noninflamed patients and selected into the subgroup analysis. The correlation analysis showed that serum albumin was still negatively correlated with PWV (r = --0.66, P \< 0.001; [Figure 1B](#f1-vhrm-4-0871){ref-type="fig"}). Because there were also significant correlations between serum albumin and age and diabetic status (data not shown), partial correlation analysis was performed to control the possible effect of age and diabetic status on PWV. The partial correlation showed that there was still negative correlation between serum albumin and PWV (r = --0.412, P \< 0.05). Given the relatively small sample in this non-inflamed subgroup, multiple stepwise regression analysis was not performed.

Discussion
==========

In these CAPD patients studied, there was a close association between serum albumin and PWV: 1) serum albumin was negatively correlated with PWV; 2) serum albumin was one of the independent determinants of PWV; and 3) the inverse association between serum albumin and PWV could still be observed in a subgroup of patients without evidence of inflammation.

The aortic PWV reflects central arterial stiffness ([@b26-vhrm-4-0871]). Previous studies have shown that PWV is a predictor of cardiovascular outcome in the general population ([@b20-vhrm-4-0871]) and in patients with hypertension ([@b2-vhrm-4-0871]; [@b24-vhrm-4-0871]; [@b7-vhrm-4-0871]), diabetes ([@b11-vhrm-4-0871]), and hemodialysis ([@b4-vhrm-4-0871]) patients. On the other hand, the attenuation of PWV is related to improved clinical outcome in dialysis patients ([@b19-vhrm-4-0871]). Therefore, PWV was employed as the marker of aortic stiffness in the present study.

In univariate correlation analysis, we found that PWV was negatively associated with serum albumin, but positively correlated with age, diabetic status, SBP, and CRP ([Table 2](#t2-vhrm-4-0871){ref-type="table"}). While PWV failed to show any correlation with other possible affecting factors, such as sex, height, dialysis duration, DBP, antihypertensive medication, ECW, serum calcium, phosphate, total cholesterol and CRP. Given the limitation of univariate analysis in differentiating confounding factors, multiple stepwise regression analysis was further performed by including all these possible factors as independent variables. The regression analysis identified that SBP, age, serum albumin and total cholesterol were independent determinants of PWV in these dialysis patients. These four factors could explain about 62.7% of variation in PWV in principle (adjusted R Square = 0.627, [Table 3](#t3-vhrm-4-0871){ref-type="table"}). It should be noted that the effect of serum albumin on PWV was independent from the mediating effect of inflammation, which was not only demonstrated in multiple regression analysis but also in the subsequent subgroup analysis. To further clarify the confounding effect of inflammation on the relationship between serum albumin and PWV, a subgroup of patients without inflammation (CRP \< 3 mg/L, n = 30) were taken out and studied separately. The univariate correlation analysis showed that serum albumin was still negatively correlated with PWV ([Figure 1B](#f1-vhrm-4-0871){ref-type="fig"}). This inverse association between serum albumin and PWV could still be observed even controlling age and diabetic status in partial correlation analysis. In line with our observation, a previous study showed that a lower albumin level was associated with a multiply adjusted risk of 2.1 for 4-year mortality compared with those with higher albumin in persons who did not have evidence of inflammation (indicated by a high interleukin-6 level) ([@b28-vhrm-4-0871]).

The close association between lower serum albumin and increased PWV, the marker of increased aortic stiffness, might be explained by the following mechanisms. First, there were evidences that hypoalbuminemia was associated with increased oxidative stress in dialysis patients. Using plasma protein thiol oxidation and protein carbonyl formation as indictors of oxidative stress, [@b12-vhrm-4-0871] found that oxidative stress was significantly elevated in hypoalbuminemia group as compared with normoalbuminemia group. Increased oxidative stress, in turn, could accelerate atherosclerosis process. On the other hand, intravenously administered albumin was associated with increased plasma thiol levels, which improved antioxidant function ([@b27-vhrm-4-0871]). Second, hypoalbuminemia was also found to have a close association with endothelial dysfunction in nephrotic syndrome ([@b21-vhrm-4-0871]; [@b15-vhrm-4-0871]) and dialysis patients ([@b6-vhrm-4-0871]). Von Willebrand factor, an established index of endothelial dysfunction in patients with atherosclerotic cardiovascular disease ([@b25-vhrm-4-0871]; [@b5-vhrm-4-0871]), was found to correlate inversely with serum albumin in hemodialysis patients ([@b6-vhrm-4-0871]). Third, it was well known that hypoalbuminemia was often accompanied with dyslipidemia in patients with nephrotic syndrome ([@b8-vhrm-4-0871]; [@b22-vhrm-4-0871]) and dialysis patients ([@b30-vhrm-4-0871]; [@b29-vhrm-4-0871]). Dyslimiemia played an important role in the pathogenesis of atherosclerosis and was one of the long identified risk factor for cardiovascular disease. There was also a report that in CAPD patients, albumin infusion would significantly decrease the levels of lipoprotein (a), an independent risk factor for atherosclerotic cardiovascular disease ([@b34-vhrm-4-0871]). The aforementioned atherogenic mechanisms related to hypoalbuminemia might explain why hypoalbuminemia was identified as an independent risk factor for elevated PWV in CAPD patients.

There were some limitations in the present study. First, the cross-sectional design in this study limited our ability to infer a causal relationship between serum albumin and PWV. Indeed, totally opposite explanation might also reasonable. As a result, the relationship between serum albumin and pulse wave velocity should be verified in future interventional studies. Second, although a number of potential confounding factors such as sex, age, diabetes, lipid profile, antihypertensive medication, calcium and phosphate levels were controlled in multiple regression analysis, the existence of other unrecognized confounding variables was always possible. Third, this study was conducted in relatively older dialysis patients (mean age was 63 years), therefore, the extrapolation of the result in this study to other population, especially younger patients and nondialysis patients may not be appropriate. Indeed, there was a report that the association between hypoalbuminemia and markers of arterial stiffness could not be observed in a nondialysis population ([@b14-vhrm-4-0871]).

In conclusion, this study performed in dialysis patients showed that serum albumin was independently associated with PWV. The inverse association between serum albumin and PWV suggested that increased arterial stiffness might be the link between hypoalbuminemia and increased cardiovascular events and mortality in dialysis patients.
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###### 

Demographic characteristics of the study population

  ------------------------------------- --------------
  Number of patients                    62
  Sex, male/female                      27/35
  Age, year                             63 ± 12
  Height, cm                            157 ± 14
  Weight, kg                            61 ± 17
  Dialysis duration, month              23 ± 22
  Antihypertensive medication, Yes/No   52/10
  Primary diagnosis                     
    Chronic glomerulonephritis,         30.6%
    Hypertension                        24.2%
    Diabetes                            17.7%
    Tubulointerstitial nephritis        11.3%
    Unknown                             16.1%
  Systolic blood pressure, mmHg         149 ± 23
  Diastolic blood pressure, mmHg        84 ± 13
  Extracellular water, L                14.7 ± 3.2
  Serum calcium, mmol/L                 2.25 ± 0.23
  Serum phosphate, mmol/L               1.56 ± 0.43
  Total cholesterol, mmol/L             4.96 ± 1.06
  Serum albumin, g/L                    37 ± 4
  Serum CRP, mg/L                       6.6 ± 6.8
  rKt/V                                 0.48 ± 0.55
  pKt/V                                 1.27 ± 0.44
  tKt/V                                 1.75 ± 0.55
  PWV, m/s                              11.96 ± 2.27
  ------------------------------------- --------------

**Abbreviations:** CRP, C-reactive protein; rKt/V, renal Kt/V; pKt/V, peritoneal Kt/V; tKt/V, total Kt/V (rKt/V+pKt/V); PWV, pulse wave velocity.

###### 

Correlation analysis between PWV and other possible affecting factors

  Variables                            Correlation coefficient   P value
  ------------------------------------ ------------------------- ---------
  Sex: female = 1, male = 0            --0.043                   NS
  Age                                  0.35                      0.005
  Height                               --0.036                   NS
  Diabetes Mellitus: yes = 1, no = 0   0.292                     0.021
  Dialysis duration                    0.132                     NS
  SBP                                  0.493                     \<0.001
  DBP                                  --0.006                   NS
  AHM: yes = 1, no = 0                 0.133                     NS
  Extracellular water                  0.241                     0.077
  Calcium                              --0.103                   NS
  Phosphate                            --0.244                   0.056
  Total cholesterol                    0.148                     NS
  CRP                                  0.295                     0.036

**Abbreviations:** SBP, systolic blood pressure; DBP, diastolic blood pressure; AHM, antihypertensive medication; CRP, C-reactive protein.

###### 

Multiple stepwise regression analysis for assessing the determinants of C-F PWV in CAPD patients

  Model     β         95% CI            P value
  --------- --------- ----------------- ---------
  SBP       0.615     0.041, 0.091      \<0.001
  Age       0.414     0.029, 0.118      \<0.01
  Albumin   --0.315   --0.315,--0.035   \<0.05
  TC        0.275     0.082, 1.098      \<0.05

**Notes:** Adjusted R Square = 0.627. Adjusted for sex (male = 0, female = 1), height, dialysis duration, diabetic status (yes = 1, no = 0), diastolic blood pressure, antihypertensive medication (yes = 1, no = 0), C-reactive protein, serum calcium, serum phosphate and extracellular water.

**Abbreviations**: SBP, systolic blood pressure; TC, total cholesterol.
